It should be emphasized that TERT gene mutations did not predict the risk of death linked to TERT upregulation at all (p = 0.83, HR = 1.03), indicating that prognostic assessment of patients with oral cancer linked to TERT upregulation should be performed by immunohistochemistry of the protein in tumor tissue. This evidence concerns the gene TERT and neoplasm.